Prediction of prognosis and resectability using MR imaging, clinical, and histopathological findings in patients with perihilar cholangiocarcinoma
- 30 April 2021
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (9) , 4159-4169
Abstract
Purpose To predict poor overall survival (OS) and risk of residual tumor after surgery using MR imaging, clinical, and histopathological findings in perihilar cholangiocarcinoma. Methods 196 patients with perihilar cholangiocarcinoma who underwent preoperative MRI and curative-intent surgery were retrospectively included. MRI findings were assessed by two radiologists. Clinical characteristics and histopathological results such as serum carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), T and N stage, and resection status, were also investigated. Cox regression analysis and the Kaplan–Meier method were used to identify prognostic factors for OS. We further analyzed the correlation between MRI features and residual tumors using logistic regression analysis. Results The median OS was 25.0 ± 26.6 months. T stage (hazard ratio [HR] 6.26, p = 0.014), N stage (HR 1.86, p = 0.002), CA-19-9 >37 U/mL (HR 2.06, p < 0.001), enlarged LN on MRI (HR 1.69, p = 0.006), and residual tumor (HR 1.52, p = 0.034) were important predictors of poor survival. The 5-year OS of the complete resection group (n = 107) was significantly better than that of the residual tumor group (n = 89) (35.5% vs. 18.8%, p = 0.002). Additionally, peritumoral fat stranding (odds ratio[OR] 2.09, p = 0.027), Bismuth type III/IV (OR 1.95, p = 0.022), and common bile duct (CBD) involvement (OR 2.3, p = 0.008) on MRI were important predictors of residual tumors in univariate analyses. However, absence of peritumoral fat stranding was a significant independent predictor for complete resection (OR 1.99, p = 0.048) and showed the highest sensitivity, at 79.8%. Conclusion MR imaging, clinical and histopathological results are useful for predicting poor survival after surgery for perihilar cholangiocarcinoma. Furthermore, MRI findings, including peritumoral fat stranding, CBD involvement, and Bismuth type, are important for the prediction of residual tumors.Keywords
This publication has 42 references indexed in Scilit:
- Prognostic Impact of Preoperative Imaging Parameters on Resectability of Hilar CholangiocarcinomaHPB Surgery, 2013
- Role of Adjuvant Chemoradiotherapy for Resected Extrahepatic Biliary Tract CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Gadobutrol-enhanced, Three-Dimensional, Dynamic MR Imaging With MR Cholangiography for the Preoperative Evaluation of Bile Duct CancerInvestigative Radiology, 2010
- Hilar Cholangiocarcinoma: Current ManagementAnnals of Surgery, 2009
- Evaluation of the Gross Type and Longitudinal Extent of Extrahepatic Cholangiocarcinomas on Contrast-Enhanced Multidetector Row Computed TomographyJournal of Computer Assisted Tomography, 2009
- Surgery for extrahepatic cholangiocarcinoma: predictors of survivalHPB, 2008
- Contrast‐enhanced MRI combined with MR cholangiopancreatography for the evaluation of patients with biliary strictures: Differentiation of malignant from benign bile duct stricturesJournal of Magnetic Resonance Imaging, 2007
- Biliary Ductal Involvement of Hilar CholangiocarcinomaJournal of Computer Assisted Tomography, 2007
- Forty Consecutive Resections of Hilar Cholangiocarcinoma With No Postoperative Mortality and No Positive Ductal MarginsAnnals of Surgery, 2004
- Staging, Resectability, and Outcome in 225 Patients With Hilar CholangiocarcinomaAnnals of Surgery, 2001